首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study
【24h】

Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study

机译:肌醇肌醇对多囊卵巢综合征红细胞改变的改善作用:体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

Polycystic ovary syndrome (PCOS)is a gynecological endocrine disorder which is associated with systemic inflammatory status inducing red blood cells (RBC) membrane alterations related to insulin resistance and testosterone levels which could be greatly improved by myo-inositol (MYO) uptake. In this study we aim to evaluate the effect of MYO in reducing oxidative-related alterations through in vitro study on PCOS RBC. Blood samples from two groups of volunteers, control group
机译:多囊卵巢综合征(PCOS)是一种妇科内分泌紊乱,其与诱导与胰岛素抵抗和睾酮水平相关的红细胞(RBC)膜改变有关的型炎症状态有关,所述胰岛素抵抗和睾酮水平可以通过Myo-intositol(Myo)摄取而大大提高。 在这项研究中,我们的目标是通过对PCOS RBC的体外研究来评估MyO对减少氧化相关的改变的影响。 来自两组志愿者,对照组的血液样本

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号